VeriSee DR, an AI-based diagnostic software for diabetic retinopathy, leverages AI deep learning techniques to produce diagnosis results similar to that of professional ophthalmologists, which has a screening accuracy of 93%.

VeriSee DR 為一人工智慧糖尿病視網膜病變輔助診斷系統，透過安裝 VeriSee DR 軟體於眼底鏡連接的電腦中，先進行眼底圖影像品質的確認，醫事人員確認無誤後再分析糖尿病病患的眼底圖來分析其視網膜病變狀況。

Sep 30, 2022 · VeriSee DR, a SaMD (software as a medical device), is the flagship AI product developed by Acer Group. The software uses AI to analyze images of diabetic patients’ retinas with ophthalmology-level of accuracy and give an immediate referral recommendation.

Mar 12, 2025 · Acer today announces the availability of VeriSee DR, an ophthalmic AI-assisted diagnostic solution for diabetic retinopathy (DR), to promote its early detection in the Philippines and other Southeast Asia (SEA) countries.

VeriSee DR is a diagnostic software for diabetic retinopathy (DR). It uses AI and assists healthcare professionals to analyze retinal images for signs of DR. The patient will receive...

Oct 6, 2021 · VeriSeeDR is a diagnostic software for diabetic retinopathy (DR). It utilizes artificial intelligence (AI) to assist healthcare professionals to analyze retinal images for signs of DR and immediately outputs recommendation on referral to ophthalmologists. The analyzed results can be edited with additional annotations before exporting as a PDF file.

Jan 1, 2021 · In this study, we used an open-access dataset as well as a local dataset collected in Taiwan to train the VeriSee™ for diagnosing DR, and to validate its efficacy by comparing the precision rate of diagnosis with those made by internal physicians and ophthalmologists.

VeriSee DR is an AI-assisted diagnostic software for diabetic retinopathy (DR) that analyzes the image for signs of diabetic retinopathy and identifies high-risk DR patients.

VeriSee DR 是一個 AI 輔助診斷糖尿病視網膜病變 (DR) 的軟體，適用於糖尿病患的眼底鏡檢查產生的彩色視網膜照片，利用 AI 對糖尿病視網膜提供分類【定期追蹤】 vs. 【建議轉診眼科】的建議，用以用以醫事人員操作和初步篩檢，以及輔助醫師診斷 ; 同時提供 4 種主要病徵的位置標示，包含微血管瘤 (Microaneurysms)、出血 (Hemorrhages)、軟滲出物 (Soft Exudates)、硬滲出物 (Hard Exudates)，準確度高達93%。

VeriSee DR is an AI-assisted diagnostics software that learns from the experiences of the many ophthalmologists from the National Taiwan University Hospital in diagnosing diabetic retinopathy (DR).